Search
for
Sort by
Research 30 of 1000+
- Anatomic location of primary melanoma: Survival differences and sun exposure
- Correction: RASopathic Skin Eruptions during Vemurafenib Therapy
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Cutaneous melanoma, prostate-specific antigen testing and the subsequent risk of prostate cancer diagnosis: a prospective analysis of the 45 and Up Study
- Scalp Melanoma: A High-Risk Subset of Cutaneous Head and Neck Melanomas with Distinctive Clinicopathological Features
- Aberrant Activation of the Hedgehog Pathway in Cutaneous Melanoma: Therapeutic Potential of Pharmacological Inhibitors
- Malignant Melanoma and Its Stromal Nonimmune Microecosystem
- Successful in situ 5-aminolevulinic acid photodynamic therapy in a 53-year-old female with cutaneous squamous cell carcinoma
- Uncovering the complex relationship between balding, testosterone and skin cancers in men
- INTERFERONS IN DERMATOLOGY
- Roles of the Hedgehog Signaling Pathway in Cutaneous Physiology and Oncology
- Hair shaft miRNA‐221 levels as a new tumor marker of malignant melanoma
- Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents
- Carcinogenesis of the Human Scalp. An Immunometabolic Centered View
- Illuminating microflora: shedding light on the potential of blue light to modulate the cutaneous microbiome
- Lentiginous melanoma. A clinically malignant entity that histopathologically seems benign. Case study harbouring BRAF V 600R mutation
- ‘Malignant melanoma microecosystem’: Immunohistopathological insights into the stromal cell phenotype
- Dermoscopy of Thick Scalp Melanoma: Is It Always an Easy Diagnosis?
- Updates from the British Association of Dermatologists 91st Annual Meeting, 5-7 July 2011, London, U.K.
- Reduced SMAD2/3 activation independently predicts increased depth of human cutaneous squamous cell carcinoma
- RASopathic Skin Eruptions during Vemurafenib Therapy
- Advances in Cell-Mediated Drug Delivery for Dermatologic Diseases: Mechanisms and Current Applications
- Dermoscopy: distinguishing malignant tumors from benign
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment
- Ottawa, Ontario, Canada, February 13–16, 2013
- Usefulness of Dermoscopy to Provide Accurate Assessment of Skin Cancers
- Biocompatible exosomes derived from <i>Pinctada martensii</i> mucus for therapeutic melanin regulation via α-MSH/NF-κB/MITF pathway
- Microneedle-Mediated Transdermal Drug Delivery for the Treatment of Multiple Skin Diseases
- Contents